Colorectal Cancer Therapeutics Market Size

Colorectal Cancer Therapeutics Market size was over USD 20.33 Billion in 2023 and is projected to exceed USD 69.36 Billion by the end of 2036, witnessing over 9.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of colorectal cancer therapeutics is evaluated at USD 22.14 Billion. The growth of the market is primarily attributed to the rising prevalence of colorectal cancer across the globe, increasing awareness of the serious impacts of colorectal cancer, and growing diagnostic methods. For instance, nearly 2.3 million cases of colorectal cancer were diagnosed in 2020, making it the third most prevalent cancer type worldwide.

Further, systematic treatments include chemotherapy, targeted therapy, and immunotherapy. Rising awareness in people regarding cancer, and increasing count of colorectal cancer screenings are robustly driving the growth of the market. It is observed that every year, more than 16 million colonoscopies are conducted in the United States.